Protalix Biotherapeutics (PLX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PLX Protalix Biotherapeutics

Watchlist

1.200
-0.020-1.64%

Trading Nov 7 15:33 ET

88.25MMarket Cap-6666P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Protalix BioTherapeutics to Announce Third Quarter 2024 Financial and Business Results on November 14, 2024
PR NewswireNov 7 06:50 ET
Express News | Protalix BioTherapeutics To Present Data From Phase I Clinical Trial Of PRX-115 Recombinant PEGylated Uricase Product Candidate
BenzingaOct 25 07:19 ET
Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024
PR NewswireOct 25 07:18 ET
Protalix BioTherapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PR NewswireSep 4 06:50 ET
Express News | Protalix BioTherapeutics Announced That It Has Repaid In Full Its 7.50% Senior Secured Convertible Promissory Notes Financed Entirely With Available Cash
BenzingaSep 3 06:51 ET
Is Protalix BioTherapeutics, Inc. (PLX) The Best Rated Penny Stock To Buy According to Analysts?
Yahoo FinanceAug 30 08:38 ET

Comments

Jaguar8

Oct 25 06:43

NEWS

$Protalix Biotherapeutics (PLX.US)$
Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024
Protalix BioTherapeutics (NYSE American:PLX) announced it will present data from its phase I clinical trial of PRX-115, a recombinant PEGylated uricase product candidate for uncontrolled gout treatment, at the ACR Convergence 2024. The presentation, titled 'Prolonged Plasma Urate-Lowering After a Single Intravenous Administration of PRX-115,' will be del...

Jaguar8

Jun 13 06:35

NEWS

$Protalix Biotherapeutics (PLX.US)$
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout
Protalix BioTherapeutics (NYSE American: PLX), a biopharmaceutical firm, will host an in-person investor day on June 26, 2024, at the Lotte Palace New York Hotel. The event will begin at 8:30 a.m. EDT. Key opinion leaders, including Aleš Linhart of Charles University and Naomi Schlesinger of the Univers...

Jaguar8

May 29 07:40

NEWS

$Protalix Biotherapeutics (PLX.US)$
Protalix BioTherapeutics to Present at the 2024 BIO International Convention
Protalix BioTherapeutics (NYSE American: PLX), a biopharmaceutical company specializing in recombinant therapeutic proteins via its ProCellEx® plant cell-based system, announced its participation at the 2024 BIO International Convention in San Diego, California. The convention, hosted by the Biotechnology Innovation Organization (BIO), is the largest industry event, gathering glo...